China Pharma Holdings (CPHI) Share-based Compensation (QoQ) (2010 - 2026)
China Pharma Holdings (CPHI) Share-based Compensation (QoQ) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | China Pharma Holdings | 42.13 Mn | 41.82 Mn | 83,566.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.08% |
| Mar 31, 2024 | 432.93% |
| Dec 31, 2023 | -121.57% |
| Sep 30, 2023 | 487.13% |
| Jun 30, 2023 | -175.55% |
| Mar 31, 2023 | -35.48% |
| Dec 31, 2022 | 403.73% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | -33.33% |
| Mar 31, 2022 | 57,703.47% |
| Dec 31, 2021 | -96.60% |
| Dec 31, 2019 | 40.54% |
| Sep 30, 2019 | -3.01% |
| Jun 30, 2019 | -101.03% |
| Jun 30, 2013 | -200.00% |
| Jun 30, 2012 | 50.88% |
| Mar 31, 2012 | -1.09% |
| Dec 31, 2011 | 0.00% |
| Sep 30, 2011 | 42.53% |
| Jun 30, 2011 | -4.37% |